In Brief: ChemTrak
This article was originally published in The Tan Sheet
Executive Summary
ChemTrak: Submits premarket approval application to FDA for its home HIV test kit, making it the second firm to seek agency approval for such a product; J&J subsidiary Direct Access Diagnostics has a PMA pending for its home HIV testing service. The ChemTrak test involves pricking the finger with a lancet, placing two drops of blood on a special paper, and then sending the sample in a postage-paid mailer to ChemTrak for testing. The product was obtained by ChemTrak through the acquisition of Coonan Clinical Labs ("The Tan Sheet" Jan. 2, p. 24), which was completed on Feb. 3...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning